
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
May 14, 2026 - 00:14:45
Radio and PodcastLive Radio & Podcasts
Guest: Marisa McGinley, DO The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the horizon that may transform care for progressive patients. Explore the latest phase 3 data on BT...
The Future of MS Management: Novel Agents and Clinical Approaches is an episode from NeuroFrontiers by ReachMD. Guest: Marisa McGinley, DO The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the hor...
This episode belongs to NeuroFrontiers.
Use the player on this page to stream the episode online.
Published Aug 26, 2025, 00:03:45 long, audio available.
Guest: Marisa McGinley, DO The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the horizon that may transform care for progressive patients. Explore the latest phase 3 data on BTK inhibitors like tolebrutinib and gain insights into ongoing CAR T-cell and remyelination research, including the BEAT-MS trial, with Dr. Marisa McGinley, a neurologist at the Cleveland Clinic.
You can listen to The Future of MS Management: Novel Agents and Clinical Approaches online on Radio and Podcast. Open the player on this page to stream the available audio.
The Future of MS Management: Novel Agents and Clinical Approaches is an episode from NeuroFrontiers by ReachMD.
This episode is 00:03:45 long.
This episode was published on Aug 26, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from NeuroFrontiers when more episodes are available from the podcast feed.
You can listen to The Future of MS Management: Novel Agents and Clinical Approaches on this page when the episode audio is available from the podcast feed.
The Future of MS Management: Novel Agents and Clinical Approaches is from NeuroFrontiers by ReachMD.
Published Aug 26, 2025 and 00:03:45 long